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Background
Pursuant to 24-A M.R.S. §4302(5), the Superintendent of Insurance must report annual data to
the Joint Standing Committee on Health Coverage, Insurance and Financial Services
information related to insurance claims made for the diagnosis and treatment of Lyme
disease and other tick-borne illnesses, for all covered individuals in the State of Maine. This
report covers calendar year 2020.
Included within this report is data about:
•
•
•
•
•

the number of claims made for the diagnosis and treatment of Lyme disease and
other tick-borne illnesses;
the total dollar amounts of those claims;
the number of claim denials and reasons for those denials;
the number and outcome of internal appeals; and
the number of external appeals related to the treatment of Lyme disease and other
tick-borne illnesses.

Five kinds of reported tick-borne illnesses in Maine are included:
•
•
•
•
•

Lyme disease
Babesiosis
Ehrlichiosis (Anaplasmosis)
Rocky Mountain Spotted Fever, and
Powassan virus.

Insurance carriers licensed to write health insurance coverage in Maine are required to report
claims information for all five tick-borne illnesses to the Bureau of Insurance.
Data includes claims for all insured Maine residents; however, the data does not include
MaineCare or Medicare claims. Respondents include active insurers with authority to write
health insurance in Maine. There was a 100% response rate from insurers.
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Tick-Borne Illness Claims by Category
Table 1 shows what carriers reported for the number of claims submitted, paid and denied
by category of tick-borne illness, as well as the total amount paid for claims. These figures
represent the number of claims reported, not the number of enrollees with a tick-borne
illness. One enrollee may have several claims within the calendar year relating to a tickborne illness.
The reported data includes claims made for the diagnosis and treatment of tick-borne illnesses
for covered individuals in Maine in 2020.
The “Percentage of Claims Paid” column is calculated by dividing the number of claims paid for
a category (e.g., Lyme) by the number of claims submitted for that category.
Table 1. Tick-Borne Illness Claims by Category, 2020
% of Claims
Category
Submitted
Paid
Denied
Total Paid
Paid
Lyme Disease (singular)
4,282
3,404
878
79.50%
$638,807
Multiple Tickborne
Illnesses (any
combination)

120

84

36

70.00%

$19,476

Other (any singular
tickborne disease other
than Lyme)

833

679

154

81.51%

$525,668

5,235

4,167

1,068

79.60
%

$1,183,951

Total:
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Reasons for Denied Tick-Borne Illness Claims
Table 2 provides the reasons given for denied claims related to any treatment for tick-borne
illnesses. A claim may have multiple reasons for denial.
The top three reasons for denial (excluding “other reasons”) were Duplicate Claim, More
Information Requested/Not Received, and Non-Participating Provider.
In the Other Reasons for Denial category “Date Received Not Timely” was the top reason
reported.
Table 2. Reasons for Denied Tick-Borne Illness Claims, 2020
Reasons for Denial
Considered Experimental/Investigational
Coverage Terminated
Duplicate Claim
Incorrect Coding
Maximum Benefits Exceeded
More Information Requested/Not Received
No Pre-Authorization
Non-Participating Provider
Not a Covered Benefit
Not Medically Necessary
Pre-existing Conditions Exclusion
Other Reasons for Denial
Total:

Number of
Denied Claims
0
86
259
29
10
164
17
120
36
27
1
336
1,085
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Appeals/Reconsiderations/External Reviews for All Tick-Borne
Illnesses
As indicated in Table 3, there were seven internal appeals or reconsiderations conducted by
the insurance companies reporting data to the Bureau of Insurance, and the Bureau had no
requests for independent external reviews relating to tick-borne illnesses in 2020.
Table 3. Number of Appeals/Reconsiderations and External Reviews for
All Tick-Borne Illnesses, 2020
Upheld Overturned
Other
Total
Appeals/Reconsideration (Internal)
5
2
0
7
Independent External Reviews
Total:

0
5

0
2

0
0

0
7
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